Jumo Health and PRA Health Sciences Partner to Support iCAN at the 2019 Summit

KANSAS CITY, Missouri- At the 2019 iCAN Summit, Jumo Health partnered with PRA Health Sciences to co-lead a workshop about pediatric education in clinical trials, focusing on how to tailor educational materials for each study. The  interactive session included an exercise where iCAN youth advisors learned how clinical study materials are developed. Through this exercise, iCAN youth advisors saw the unique way Jumo Health’s resources depict real patient stories and marry visual and verbal information to help study participants understand and act upon their physician’s instructions. The workshop concluded with iCAN youth advisors participating in a contest to create a comic book character based on their likeness. The top 3 entrants won a custom poster, created by Jumo Health, of their comic book characters. 

About Jumo Health

Jumo Health develops age appropriate, educational resources for patients and caregivers for use throughout their medical journey.

By working with providers, manufacturers, and advocacy groups, we ensure our resources are available at the moment of diagnosis, during a treatment regimen, or while participating in a clinical trial. With the belief that an informed patient is a compliant patient, Jumo Health designs practical solutions using popular mediums. With experience providing resources to more than 65 countries in 55 languages, and covering more than 200 topics, our mixed media solutions range from comic books to animated videos, are evidence based and peer reviewed, and pay careful attention to health literacy and reading comprehension barriers. Visit jumohealth.com to learn more.

Join Our Mailing List
Quick Links

Checks should be made payable to:

International Children’s Advisory Network, Inc.

400 West Peachtree St., NW

Suite 4-5027

Atlanta, GA 30308

Email: info@icanresearch.org


iCAN has operated under the Foundation for Children, Inc, a registered 501(c)3 since 2015 and has filed for its own 501(c)3 status, which is currently pending.